We hope that further validation of these results and an attempt to understand basic biological changes driven by increased ESR1 gene dosage as well as by ESR1 PvuII and UGT2B15*2 polymorphisms will contribute to the understanding of breast cancer biology. This evidence concerns the gene ESR1 and breast carcinoma.